Key Takeaways
- LRCX reached a record peak of $275.99, climbing 5.56% in a single trading session
- Annual performance shows remarkable 252% gain for shareholders
- Wall Street analysts boost price targets between $310 and $340
- Senior VP Neil Fernandes executed a pre-arranged sale worth $4.6M on May 1
- New U.S. export controls targeting China’s Hua Hong could impact future revenue
Shares of Lam Research (LRCX) reached an unprecedented peak of $275.99 during trading on May 5, 2026, surging more than 5.5% during the session. This impressive rally caps off a spectacular twelve-month period that has delivered 252% in total returns, elevating the semiconductor equipment manufacturer’s valuation to $343 billion.
Lam Research Corporation, LRCX
Top-line growth has accelerated approximately 27% over the trailing twelve-month period. The firm’s Piotroski Score stands at an optimal 9, according to metrics monitored by InvestingPro, signaling robust financial strength.
Currently, shares command a price-to-earnings multiple of 48.75. InvestingPro’s proprietary assessment suggests LRCX may be trading above its calculated Fair Value benchmark.
Analyst firms have been actively revising their projections upward. Following fiscal third-quarter results that exceeded both internal forecasts and Street expectations, Stifel elevated its price objective to $325 while maintaining a Buy recommendation.
TD Cowen adopted an even more optimistic stance, pushing its target to $340. The firm highlighted expanding market penetration in foundry and DRAM segments, alongside anticipated expansion in NAND wafer fabrication equipment expenditures.
Cantor Fitzgerald reaffirmed its Overweight rating with a $320 price objective. The firm referenced enhanced prospects for wafer fabrication equipment throughout calendar 2026, projecting industry expansion of no less than 27%.
UBS maintained its Buy rating at a $310 target, emphasizing that LRCX is positioned at the beginning of what analysts characterize as an artificial intelligence-fueled expansion phase.
Executive Stock Transaction Under Scrutiny
Senior Vice President Neil Fernandes divested 18,170 shares on May 1 at $255.14 per share, generating approximately $4.64 million in proceeds. This transaction occurred through a Rule 10b5-1 trading arrangement that Fernandes established on November 17, 2025.
Following this sale, Fernandes maintains direct ownership of 66,129 shares. Additionally, he controls slightly more than 1,015 shares indirectly via his 401(k) retirement account.
Scheduled transactions of this nature are standard practice for corporate executives and typically don’t signal concerns about future stock performance.
Export Controls Create Regulatory Headwinds
Despite the positive momentum, challenges remain. The U.S. Department of Commerce implemented new export limitations affecting chip equipment deliveries to Hua Hong, China’s number-two semiconductor manufacturer. Lam Research was included among the American equipment suppliers impacted by these measures.
These regulatory restrictions initially sparked selling pressure across chip equipment stocks when first announced. The complete financial consequences for LRCX stemming from these export controls remain unclear.
Fourth-quarter fiscal projections exceeded analyst expectations. The organization is already achieving profitability and revenue benchmarks initially projected for calendar year 2028.
LRCX’s third-quarter fiscal performance surpassed both Stifel’s projections and broader consensus estimates, catalyzing the latest round of upward target revisions from Wall Street.
Shares concluded trading on May 5 at their record intraday peak of $275.99.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
